New pacemaker strategy could cut heart failure deaths after valve surgery
NCT ID NCT07434193
First seen Feb 25, 2026 · Last updated May 15, 2026 · Updated 6 times
Summary
This study looks at whether a special pacemaker, called cardiac resynchronization therapy (CRT), can help people with heart failure who develop a heart block after a minimally invasive aortic valve replacement (TAVI). About 360 participants will be randomly assigned to get the pacemaker or standard care. The goal is to see if the pacemaker reduces hospitalizations and deaths related to heart failure over one year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Semmelweis University, Heart and Vascular Center
RECRUITINGBudapest, 1122, Hungary
Contact Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.